Using an Educational Training Module to Increase Knowledge, Attitudes and Practices of Malaria among Medicine Vendors in Yobe, Nigeria by Katagum, Yahaya Mohammed et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Using an Educational Training
Module to Increase Knowledge,
Attitudes and Practices of Malaria
among Medicine Vendors in Yobe,
Nigeria
Yahaya Mohammed Katagum, Hayati Binti Kadir Shahar,
Faisal Bin Ibrahim, Anisah Baharom and Rafee Baharudin
Abstract
This training module focuses on providing basic guidance on the current
recommended approaches regarding malaria basic information, signs/symptoms,
case detection, treatment, referral, and effective prevention strategies. The module
can be used for in-service training programs on malaria or to assist in improving
other health educator’s work as well as serve as referral handbook for practicing
health professionals. It can thus be used as a stand-alone training or together with
modules dealing with other aspects of malaria control, prevention and elimination.
The module uses a problem-solving approach to facilitate understanding and
thereby motivate trainees on improved malaria case management. In essence, the
training aims to generally improve the knowledge, attitudes and practices (KAP) of
the most common handlers of malaria cases in this part of the world, the training
module is then expected to improve services obtained by the majority of patients on
malaria. On completion of training using this module, trainees will have acquired
appreciable knowledge and skills on malaria basic-information, signs/symptoms,
case detection/differentials, recommended drug treatment/appropriate dosing,
indication for referral of complicated cases, effective prevention methods and the
need to sensitise communities to stand up against malaria.
Keywords: malaria KAP training, case detection, management and prevention,
medicine vendors
1. Introduction
Malaria remains a major global public health and development challenge over
the years and in its World Malaria Report 2019, the World Health Organisation’s
(WHOs) global tally of malaria in 2018 alone was estimated at 228 million cases and
405,000 deaths [1]. Malaria is holo-endemic in many parts of sub-Saharan Africa
thereby infecting citizens all year round and hence impacting the most devastation
in this region. Worldwide, about 88 countries still remain at risk of malaria, with the
types of species, severity and disease trends depending on the geographical location.
1
One of the greatest challenges facing malaria endemic countries with regards to
malaria containment efforts is the lack of proper basic information, poor diagnosis
and hence lacking early treatment of uncomplicated cases which progresses to the
deadly severe stages, poor treatment and referral practices and poor preventive
strategies [2].
Problems of malaria endemicity cannot be unconnected to the widely claimed
inadequately trained health manpower and hence poor practices of the health per-
sonnel, these health personnel comprise mostly of Patent Medicine Vendors
(PMVs) in most rural areas of sub-Saharan Africa. It has been reported that up to
60% of all malaria cases in this sub-region are preferentially first treated by the
PMVs and these services leaves much to be desired [3], a situation which informed
the development of this training in an attempt to give a more pragmatic approach to
PMV the training program. Patent Medicine Vendors are individuals that usually
engage in the stocking and sale of Over-the-Counter (OTC) drugs as well as provi-
sion of other basic healthcare services and as such, they assume the most common
sources of antimalarial treatment throughout Sub-Saharan Africa as they also play a
potentially critical role in the struggle against malaria [4].
To facilitate learning by all participants, the training strategies will encourage
participants to learn from each other as well as from the researcher / facilitators,
particularly in the form of lecture sessions, group discussions, demonstration exer-
cises, role plays, brainstorming exercises and collectively tackling case studies. Each
participant will therefore be expected to take part actively throughout the course. In
working through the modules, there will be opportunities to put into practice,
individually or collectively, what has been learnt. Various strategies were then
implored to achieve this objective.
Presentations: Formal presentations such as lectures from the facilitators will be
limited to a minimum and this will be presented in the form of explanation to the
principles, basic knowledge, and then practical experiences with the class in session.
All information provided in sessions are contained in the modules and participants
need not to take much notes. Lectures will be combined with a demonstration
(physically or on slides). The participants will be asked frequently to present their
work in plenary session. This will provide experience on how to tackle arising
issues, both by presenting and by learning from the observations and suggestions
made during discussion. Posters and slides will be used to enhance learning.
Demonstrations / Practical Sessions: Demonstrations will be used to illustrate
some procedures for the diagnosis, treatment and prevention of malaria that will be
carried out. The program will include demonstration sessions so as to provide as
much practical experience in all aspects of malaria to be studied. In some sessions,
the facilitator will work with smaller sub-groups of not more than ten participants;
by limiting the size of the groups, the participants will receive extensive individual
attention and increased opportunities for learning and practice.
Group discussions / Small group discussions: Discussions will be based on topics
and cases taken from the modules which will take place during small group exer-
cises and in general plenary sessions. In these exercises, the facilitator will lead the
discussions on the selected subjects with emphasis on participation of group mem-
bers. These sessions provide opportunities for the participants to give their individ-
ual opinions and experiences, to develop ideas, learn from one another, to discuss
issues with respective colleagues, to share ideas, opinions and useful experiences,
and to finally make efforts towards drawing their own conclusions from intensive
discussions. Small group discussions are usually considered to form a valuable
component of the courses taken. Participants are also encouraged to take full
advantage of these useful sessions and to partake freely and actively in all the
discussions. At each session in the group work, there will be changes in the
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moderator and also the reporter so as to ensure that every participant gains experi-
ence in such roles and this will also ensure that tasks are shared equitably. Solving
case studies, role plays and quiz sessions will also encourage sharing ideas.
This program is designed to employ the use of various motivational enhance-
ment techniques. Motivational Enhancements can be thought of as processes
encouraging ‘the probability that a person will enter into, continue to, and adhere to
specific change strategies’. It is the responsibility of a facilitator to increase the
probabilities that participants will follow a recommended course of action towards
changes. Thus, motivation is a key part of a facilitators tasks.
For facilitators, five general principles guides behaviour during sessions. They
include:
1.Express Empathy: use skillful reflective listening to understand and accept the
participant’s contributions without judging, criticising, or blaming.
2.Develop Discrepancy: Raise / draw the participant’s consciousness and
awareness of the consequences of unhealthy, unethical practices. Remember
that participants should lead group discussions and present the need for
changes in their attitudes and practices.
3.Avoid Arguments: Arguments are counter-productive and increases
participant’s resistance to change, as such facilitators should be diplomatic.
4.Support Self-Efficacy: Facilitators must always convey to participants a feeling
of ‘You can do it, and you will succeed’ message. In essence, imparting a belief
in the ability for change is an important motivator. Hope is usually found in
the range of different approaches available. If one does not work, the
facilitator can try others.
5.Elicit self-motivational statements: this strategy helps participant’s move
beyond ambivalence.
It is important to understand the community culture and traditions. These are
the basis of community members’ values, which shape community members’ atti-
tudes on topics like malaria control. Often, these local beliefs influence community
members’ actions (or non-actions) more than any other source of information.
Community members are likely to trust what they hear from family, friends and
community leaders. Often they hear a mix of information, including local beliefs
and messages that are passed down from health workers. Some myths / local beliefs
about malaria will be reviewed in sections 4 and 6. These mix of messages can be
very confusing, so informed participants could use the opportunity to impact on
their community’s health.
The use of drugs for malaria treatment and prevention involves only drugs
recommended by the World Health Organisation (WHO) and employed by the
Nigerian government for malaria treatment within the region, this is so because
recommended drugs vary depending on region of the world due to the particular
specie of malaria infesting the region and the pattern of resistance there.
2. Malaria basic information
Table 1 below describes the training module on malaria basic information,
which comprises the session objectives, learning objectives, time duration for the
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Session Objectives To understand the basic information
on malaria
To understand the cause and how
malaria can be transmitted
To understand the malaria cycle in
man and in vector
To understand who is most
vulnerable to malaria
Duration 25 mins
Learning objectives At the end of the session, participants
should be able to:
Know what uncomplicated malaria is
Know what complicated malaria is
Be able to differentiate what causes
and what does not cause malaria
Be able to differentiate what
transmits and what does not transmit
malaria
Be able to differentiate between
suspected and confirmed malaria
Be able to differentiate between









Question & Answer sessions
(Brainstorming exercise)
Group discussions
Reflection on the module
Instructions for the facilitator 1. Begin the session by explaining the
objectives of the session
2. Get the participants to discuss
what they understand by malaria
and their experiences
3. Give a lecture on the general
information about malaria using
Lecture 2.1 below. (Notes below
each slide explain what points
need to be made)
4. Think about sections which the
participants might find difficult
and common questions they may
ask
5. Ask the series of questions (at end
of this module) and discuss the
answers
6. Ask the group questions to be
discussed
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module, training materials needed, methods used and other relevant instructions
that will assist the facilitators.
2.1 General facts about malaria
You may be wondering why the emphasis on improving knowledge, treatment
and prevention. The main reason is because malaria, being a life-threatening para-
sitic disease affects parts of the world we live in and remains the major public health
problem in Nigeria. It is an avoidable cause of death and illness in children and
adults. In Nigeria, malaria continues to be endemic and is the first major cause of
morbidity and mortality among the most vulnerable groups- children under 5 years,
pregnant women and people living with HIV/Aids. Malaria is characterised by a
stable, perennial, transmission in all parts of the country. Transmission is higher in
the wet season than in the dry season. This seasonal difference is more striking in
the northern part of the country.
According to the World Malaria Report (2013), there was a worldwide estimate
of 207 million cases of malaria and an estimated 627 000 deaths in 2012 alone. 81%
of these cases and 91% of the deaths were from sub-Saharan Africa [5], and Nigeria
alone bears up to 25% of the burden [6]. Again, about 63% of hospital attendance in
the Nigerian health care facilities are caused by malaria which is also the cause of
absence in workplace / schools, in addition to a huge health expenditure to house-
holds leading to a total estimated economic loss to the country of up to 132 billion
Naira per year [6].
Note that, in the absence of an effective vaccine, malaria treatment and
prevention still remains the vital strategies of malaria control, especially to you
PMVs, who are usually the first place of call to the bulk of community resi-
dents.
• What is Malaria?
□ Malaria is a serious and sometimes fatal disease caused by a parasite called
plasmodium which infects human blood cells. (A parasite is an organism that can
only exist in the body of another organism for all or part of their life)
□ There are 4 main kinds of plasmodium parasites that cause malaria in
humans. These are:
• Plasmodium falciparum (Pf).
• Plasmodium vivax (Pv).
• Plasmodium malariae (Pm).
• Plasmodium ovale (Po).
7. Try to find out if the participants
did understood the lecture by
making the class participatory
since everyone knows at-least
something on malaria
Table 1.
Summary of session on malaria basic information.
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In Nigeria 98% of malaria infections are due to P. falciparum. This parasite
causes the most deadly form of malaria, known as severe malaria. Other forms of
malaria present in Nigeria include P. ovale and P. malariae which play a minor role
with the latter being quite common as a double infection in children.
Note THAT:
□ Malaria is NOT caused by body contact, drinking contaminated water or
eating any kind of food as is the assumption in some localities.
□ Neither is malaria caused by staying under the sun, exposure to cold weather
or living in a dirty environment. Though, these conditions can aggravate malaria.
2.2 Types of vector mosquitoes
There are three common types of Mosquito Vectors:
1.Anopheline mosquito
□ wings with dark spots
□ sits at an angle of 45 degree with the resting surface
□ breeds in clean water
□ bites at late night
□ transmits malaria
2.Culex mosquito
□ usually are referred to as nuisance mosquitoes
□ usually found to breed in dirty waters
□ no unique dark spots found on the wings (usually plane dark wings)
□ appears with a hunchback when in sitting position
□ usually transmits filariasis
3.Aedes mosquito
□ are usually dark ornamental mosquito with unique white spots
□ usually breeds in clean waters found in containers / overhead tanks and wells
□ usually bites during the day time
□ bite from this specie is usually very painful
□ transmits Dengue/DHF/Chikungunia which are viral diseases
2.3 Life cycle of malaria parasite and the malaria transmission cycle
The vectors that carry malaria parasites (mosquito) prefer to feed on humans
rather than other animals. Another unique characteristic is that the vectors prefer to
feed indoors. While taking a blood meal, the female mosquito injects saliva into the
person’s blood vessels to stop the blood from clotting to make it easier to suck in.
While injecting saliva, if she is infected with malaria parasites, she injects them as
sporozoites into the person’s blood as seen in Figure 1. On the other hand, if the
person is infected, when the mosquito draws up the blood it will also take up
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malaria parasites as gametocytes, the sexual forms of the malaria parasite. After a
blood meal, the female mosquito usually finds a place to rest (usually the wall of the
house) to digest her meal, and to develop her eggs. The malaria parasites which have
been sucked up from the blood as gametocytes develop inside the mosquito over a
period of 8 to 25 days to become sporozoites in the salivary glands. At this stage the
female Anopheles mosquito becomes infective to the next person it feeds on.
Once the sporozoites get into a person with no or little immunity to malaria, they
undergo various stages of development to cause disease about 7 to 12 days later as
seen in Figure 1. Specifically, the sporozoites travel rapidly to the liver where they
enter the liver cells and divide rapidly, forming merozoites. When a liver cell is full
of merozoites, it bursts and discharges the merozoites into the blood where they
quickly enter the red blood cells. In the red blood cells, the merozoites grow and
divide again until the red blood cell bursts to release them into the blood stream to
attack other red blood cells. This is what causes the person to experience symptoms
such as fever, sweating and shivering. Some merozoites, however, change into the
male and female forms of the parasite, called gametocytes, which are taken in by the
mosquito when she sucks the blood to get her blood meal (Figure 2). The gameto-
cytes enter the mosquito’s stomach and mate to form eggs, which then in turn
become sporozoites and move to the mosquitoe’s salivary glands where they are
ready to be injected into another person. Once the mosquito bites a person and
infects him or her with sporozoites, it takes about 8 to 11 days for gametocytes to
appear in the blood. In this way and under suitable conditions, one female Anoph-
eles mosquito can transmit malaria parasites to many susceptible people during its
average life span of 20 to 25 days [7]. This transmission cycle is illustrated in
Figure 2 below. In this way, this cycle of transmission continues unless interven-
tions are used to break it.
2.3.1 The malaria transmission cycle
Key factors necessary for the process of transmission are:
Figure 1.
Life cycle of plasmodium parasites illustrating stages of the cycle.
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□ The malaria parasite itself
□ The vector / transmitting agent (i.e. the mosquito)
□ The disease reservoir which refers to the total number of the subjects in the
area carrying the malaria parasites. Their blood reservoir is where the vector obtains
the infection.
• Malaria is transmitted by the bite of an infected female anopheles mosquito of
which there are at least 400 different species. The common species are
Anopheles gambiae, A. funestus, A.arabiensis and A. melas
• Within the Anopheles gambiae complex A. gambiae s.s. is the dominant species
with A. arabiensis found more often in the Northern part of the country and A.
melas found only in the mangrove coastal zone.
2.4 Brainstorming exercises
Note: Facilitator will ask these questions and different opinions from partici-
pants discussed.
Why is malaria a major public health problem in Nigeria.
Answer: Because Malaria is a major cause of:
□ Ill health (morbidity)
□ Death (mortality)
□ Impaired child development
□ Absenteeism in school children and work places
□ Lost productivity (estimated economic loss to Nigeria is 132 billion Naira per
year)
□ Lost opportunities for economic development, e.g. tourism and foreign
investment.
How is this Anopheles mosquito specie different from other mosquitoes?
Answer: It is a large mosquito and when standing it is tilted with head down-
wards and tail upwards in the air.
Figure 2.
Malaria transmission cycle showing how malaria parasites are carried by a female Anopheles mosquito from an
infected person to a healthy one.
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Which people are most vulnerable to Malaria?
Answer:
□ Pregnant women
□ Children under 5 Years of age
□ People living with HIV/AIDS
□ People suffering from Sickle Cell disorders
□ Travellers into malaria endemic areas
Note: The first two groups (Pregnant women & Children below 5 years) are
most at risk within our communities because of their low immunity and the malaria
endemic nature of Nigeria, as such malaria is even regarded as mainly a maternal,
new-born and child health issue.
Why does only the female mosquito transmit the disease?
Answer: The female mosquito needs a blood meal for the nutrients to develop
her eggs.
Do other biting insects such as flies transmit malaria?
Answer: No. Only the female mosquito transmit malaria.
List 3 factors or reasons why people who have malaria die.
Answer:
□ Delay in starting treatment
□ Inappropriate treatment (wrong drug, incorrect dosages, non-compliance)
□ Failure to recognise and manage complications
What is the difference between Suspected Malaria and Confirmed Malaria?
Answer:
Suspected Malaria: A patient with a fever or history of fever in the last 24 hours
who lives in, or has come from anywhere in Nigeria or any other endemic country.
Previously, all patients with this definition of malaria were given treatment with an
antimalarial. Now, however, the best practice is to test all patients with suspected
malaria with a confirmatory test before giving treatment.
While Confirmed Malaria: A patient with suspected malaria who has been
shown to have malaria parasites through a parasitological test such as microscopy
(using a blood smear) or rapid diagnostic test (RDT).
What is the difference between uncomplicated malaria and severe malaria?
First: Ask participants to differentiate between the two.
Answer:
Uncomplicated Malaria is a situation where a patient presents with a history of
fever, or a fever in the last 48 hours, with no signs of severity or evidence of vital
organ dysfunction but with a positive confirmatory parasitological test;
While in severe malaria, a patient presents with a positive confirmatory parasi-
tological test and presentation of one or even more symptoms of the severe disease
state (see 3.1 below).
2.5 Reflections on this module
Think about the topics you have just been discussing. How will you use the new
knowledge you have gained when you go back to your premises? Use the questions
below to help you reflect on this. Record your thoughts on paper for discussions.
1.What is simple malaria?
2.What have I learned about malaria today that I did not know before I came to
this training program?
3.How will this new information be useful when I go back to work?
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4.What other questions do I now need to ask the trainer and get answers for?
5.What questions do I have about how I will use this information when I go back
to my community?
3. Signs & symptom / diagnosis of malaria
Table 2 below describes the training module on signs and symptoms and the
diagnosis of malaria. This comprises the session objectives, learning objectives, time
duration for the module, training materials needed, methods used and other rele-
vant instructions that will assist the facilitators to impact the training.
What is meant by Signs & Symptoms of a malaria?
First: Ask participants to assess their understanding.
Session Objectives To understand the signs and
symptoms of malaria (uncomplicated
and severe)
To identify cases of suspected
malaria
To understand that malaria can be
diagnosed based on signs and
symptoms, but this method has
limitations
To understand the use of Rapid
Diagnostic Tests (RDTs)
Duration 25 mins
Learning objectives At the end of the session, participants
should be able to:
Know the signs and symptoms of
uncomplicated & severe malaria
Know that not all fevers are caused
by malaria; and know some diseases
presenting with fevers
Appreciate the use the RDTs in
malaria confirmation
Be able to conduct appropriate






LCD projector Flip chart and
markers
Rapid Diagnostic Test kits, pair of
hand gloves, lancets, alcoholic pads
Methods used Lecture
Demonstration classes
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Answer: There are varying approaches to defining the medical meanings of
signs and symptoms. A symptom is generally subjective while a sign is objective.
Any objective evidence of a disease, such as a convulsing patient or a skin rash is
considered a sign. This can be recognised by the physician, nurse, PMV, family
members and even the patient themselves. However, headache, pain and weakness,
fatigue, and some others can only be detected by the patients themselves.
What is symptomatic diagnosis?
First: Ask participants to assess their understanding.
Answer: Symptomatic diagnosis of malaria as the name implies, is a diagnosis
that is based on the patient’s signs and symptoms which is also known as clinical
diagnosis. Malaria can then be classified into two types depending on extent of the
infection and the severity of the symptoms, they are: uncomplicated or simple
malaria and severe or complicated malaria.
3.1 Signs and symptoms of malaria
Signs and symptoms of uncomplicated malaria
Fever is usually the main symptom of malaria. It can be reported by the patients
themselves or parents of children (could be even when the temperature returns to
normal when being examined) or ascertained by taking the temperature (equal to
or higher than 37.5° under the armpit or up to 38° rectally).




□ fatigue and dizziness
□ loss of appetite
□ muscle and/or joint aches
Instructions for the facilitator 1. Begin the session by explaining the
objectives of the session
2. Get the participants to mention the
symptoms of uncomplicated
malaria they know.
3. Then give a lecture on the signs
and symptoms of both
uncomplicated and severe malaria
using “Lecture 3.1”below.
Note THAT each slide explain what
points need to be made.
4. Think about sections which the
participants might find difficult and
common questions they may ask.
5. Ask a series of questions to find out
if the participants did understood
the lecture
6. Try to simulate situations at the
participants’ place of work during
discussions and while answering
questions.
Table 2.
Summary of session on signs & symptoms/diagnosis.
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□ chills / Rigours
□ perspiration
□ digestive disorder: such as diarrhoea, abdominal discomfort
□ nausea, vomiting
□ worsening malaise
These signs and symptoms can be identified by asking the patient or their
caregiver what they have noticed since the patient started the episodes of illness.
The PMV and other healthcare providers can also take the patient’s vital signs,
including their temperature. Figure 3 shows presentations of a patient with malaria
as it transits from shivering to profuse sweating.
Signs and symptoms of severe malaria
Malaria is said to be severe or complicated when a patient presents with one or
several of the under listed signs and symptoms:
□ very high temperature (could be >40° C)
□ Prostration (i.e. generalised weakness that patient is unable to sit or walk)
□ severe anaemia (nomocytic type: a very common complication)
□ consciousness disorders (confusion, agitation, drowsiness and coma)
□ multiple convulsion (>2 in last 24 hrs)
□ repeated vomiting (hindering oral treatment),
□ dehydration (thirst, dry lips, sunken eyes and deep set fontanel),
□ icterus (jaundice),





Other clinical signs could also appear such as anaemia, acute renal injury, acute
pulmonary oedema /Adult Respiratory Distress Syndrome (ARDS), circulatory col-
lapse or shock, abnormal bleeding (e.g. bruising, bleeding gums, haemoglobinurea).
Cerebral Malaria is a common presentation of severe malaria and may cause
residual problems. A patient with malaria and altered level of consciousness, con-
fusion, delirium, hallucinations or frank coma with or without convulsion is said to
have cerebral malaria.
Note that:
□Malaria always causes fever and therefore any fever should be suspected to be
due to malaria in endemic areas.
Figure 3.
Signs and symptoms of malaria.
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□ All cases of pregnant women and children below 5 years of age presenting
with malaria are considered as severe malaria.
□ All patients presenting with conditions listed above for complicated malaria or
that which you do not fully understand, please REFER PATIENT IMMEDIATELY!
3.2 Diagnosis of malaria
3.2.1 Symptomatic malaria diagnosis
Symptomatic diagnosis of malaria is a diagnosis based on patient’s signs and
symptoms. This is also known as clinical diagnosis (suspected diagnosis). Remem-
ber that sign and symptoms of uncomplicated malaria are usually not only specific
to malaria alone, with fever being a symptom to many illnesses. So if we take all
fevers to be caused by malaria then this will certainly lead to over-diagnosis and
hence an over-use of antimalarials.
The table below (Table 3) lists other possible reasons for fever including addi-
tional signs and symptoms. Noting that fever can be caused by other illnesses, it
becomes of utmost importance to test and confirm if the fever is caused by malaria.
Should any of the additional signs and symptoms be present, the patient should
then be treated according to that disease.
3.2.2 Confirmatory malaria diagnosis
Diagnosing malaria on the basis of clinical features alone can be highly inaccu-
rate and is likely to result in significant over-treatment. It is therefore important to
establish capacity for confirmatory diagnostic testing. Effective confirmatory diag-
nostic testing can help to:
• identify patients who need antimalarial treatment;
• reduce unnecessary use of antimalarial drugs for patients without malaria;
Suspected disease Additional signs and symptoms
Common cold Running nostril, Cough
Gastroenteritis Colicky pains, Diarrhoea (bloody or not), Vomiting
Hepatitis Icterus, Enlarged spleen, Right hypochondriac pain
Meningitis Stiff neck Bulging fontanel (young infants)
Mumps Bilateral or unilateral swelling on the jaw
Pneumonia Pneumonia Cough, Fast breathing
Chest in-drawing
Tonsillitis sore throat Pains in the throat
Red inflamed throat with or without spots
Painful cervical lymph nodes
Typhoid fever Prolonged treatment not responding to appropriate antimalarial
treatment.
Dissociation between pulse rate and temperature.
Viral diseases
Which include measles and
varicella
Many cases in the neighbourhood with characteristic skin rash
Table 3.
Other diseases that fever presents as symptoms.
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Note:
□ Parasitological confirmation of suspected malaria before treatment is now
recommended for all patients because not all fevers are due to malaria [8].
There are currently two widely available options for confirmatory diagnostic
testing of malaria:
3.2.2.1 Light microscopy
Microscopy has been regarded as “gold standard” for a long time due to its
effectiveness in malaria diagnosis. Microscopy is far more sensitive than RDTs for
the detection of even low levels of P. falciparum parasitaemia (<100 parasites/μl)
and the test can differentiate into the various malaria species. To achieve an effec-
tive microscopy for malaria parasites, we require: (i) good-quality reagents and
equipment; (ii) skilled technicians with experience on how to prepare, stain films,
in addition to identifying parasites and differentiate between the different Plasmo-
dium species; and (iii) effective technical supervision and quality control of tests.
However, these may not always be available in emergency situations, it is then
easier and more beneficial for PMVs to establish a capacity for RDT.
3.2.2.2 Rapid diagnostic tests (RDTs)
In acute emergency phase of infections, limited time and resources make RDTs
preferable to microscopy for confirmation of clinical diagnosis in low-transmission
areas, and for confirming malaria in severely ill patients in moderate to high-
transmission areas. RDTs found in Nigeria are usually only sensitive to P.
falciparum. This is because P. falciparum is the most predominant species, account-
ing for about 98% of malaria cases in the country, and again, the majority of non-
falciparum species within the country cause mixed infection with P. falciparum.
The RDT differ from microscopic diagnosis of malaria through a number of ways.
Table 4 below is a comprehensive comparison between microscopy and RDTs.
3.3 Case studies
Activity 3.3.1
Instructions for the facilitator:
1.Divide the class into four groups, ask participants of each group to study the
case studies below on the description of patient’s signs & symptoms, diagnosis,
misdiagnosis and appropriate suggestions from a trained PMV (allow
10 minutes to discuss & 5 minutes for each group to present).
2.Ask what the patient is suffering from.
3.Note the various points raised by participants and use them to discuss the
various cases.
4. If the participants suspect that the patient has malaria, how do they arrive at
such conclusions?
NB. It is important to find out how they confirm this. Encourage them to
emphasise the need to test.
5.Conclude the session by discussing each group’s presentation
14
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Note that:
• RDTs are fast, convenient and can be handled by an incompetent hand. RDTs
are fairly cheap and do not require electricity.
• They are thus convenient for use by PMVs where it will improve their services
with resultant avoidance of unnecessary treatment and over-treatment with
antimalarials.
Activity 3.3.2 Read and discuss the case studies below.
Case study 1: An unknown patient comes to your PMV shop and complains that
he has fever, headache, and joint pains. He continued that the fever has been
coming on and off for about three days but he usually feels fine during the day and
in the evening he has fever.
What is he/she is suffering from and what is your line of action?
Case study 2: A mother comes to your premises with a 3 year old child that looks
very weak. The child had vomited severally and on checking, you found the child
had 40° C. discuss your actions.
3.4 Demonstration exercise
Demonstration of the use of RDT to show purple/red line in test and control
windows on strip showing antigen–antibody reaction if positive. Discuss advantages




Electricity Preferred, not necessary None
Transport / storage
conditions
Reagents stored out of direct sunlight Avoid exposure to high temperature
(4–30°C recommended)
Quality assurance Periodic re-reading of percentage of
slides by expert microscopist and
supervision
Lot testing of kits, monitoring of
storage temperature, supervision of
workers
Performance









Cost per test US$0.12–0.40 US$0.60–1.00
Technical specifications




Comparison between microscopy and RDTs.
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3.5 Reflection on the module
Participants are asked to make think about the topics they have just discussed.
How will they use the new knowledge gained when back to their premises? Also use
the questions below to help reflect. Record the thoughts on paper for discussions.
1.What is RDT and how do you compare it to microscopy?
2.What have I learned about malaria today that I did not know before I came to
this training program?
3.How will this new information be useful when I go back to work?
4.What other questions do I now need to ask the trainer and get answers for?
5.What questions do I have about how I will use this information when I go back
to my community?
4. Treatment of malaria
Table 5 below describes the training module on malaria treatment. This module
comprises the session objectives, learning objectives, time duration for the module,
training materials needed, methods used and other relevant instructions that will
assist facilitators to adequately explain malaria treatment approaches.
4.1 National treatment protocol
What is the National Malaria Treatment Protocol about?
Answer: The national treatment protocol contains recommendations on the
most effective treatment that should be given for malaria. The current protocol
recommends Artemisinin-based Combination Therapy (ACT) as the most effective
treatment for uncomplicated malaria instead of Chloroquine and SP.
4.1.1 Treatment of uncomplicated malaria
• First line treatment:
To be given to a patients with malaria when ACT are not contra-indicated.
□ Artemether /lumefantrine (AL): as a fixed dose combination, given twice a
day for (3) three consecutive days with the second dose being given 8 hours after
the first [7–9].
OR
□ Tabs Artesunate + Amodiaquine (AA): Given once daily for three (3)
consecutive days [7–9].
• Second line treatment:
To be given in the event of true treatment failure (defined as failure to clear
parasites after the three days of a full treatment course). It can also be used in
situations when ACT is not appropriate.
□ Oral Quinine: 8 hourly for seven (7) days [8, 9].
Note: Details of treatment regimens are seen in Section 4.3 below.
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4.1.2 Management of uncomplicated Malaria in pregnancy
• First Trimester
Oral Quinine is used, or a combination of oral quinine and Clindamycin.
• Second and Third Trimesters
Session Objectives To understand the essence of the National Malaria
Treatment Protocols
To understand the treatment of uncomplicated
malaria
To understand the treatment of complicated malaria
Duration 30 minutes
Learning objectives
At the end of the session, participants should be
able to:
To appreciate why government changed its policy on
malaria treatment (thereby appreciating the
shortfalls associated with the use of Chloroquine
which is still in use)
Know the treatment of uncomplicated malaria in
children, adults & pregnant women
Know the treatment of complicated malaria for all
categories of patients
To provide appropriate anti-malarial drugs to
patients of all categories
Training Materials Participant’s manual Pens & Notebook
Slides Laptop computer






Reflections on the module
Instructions for the facilitator 1. Begin the session by explaining the learning
objectives of this module
2. Give a lecture on the treatment of uncomplicated
and severe malaria in various situations using
“Lecture 4.1–4.6” below.
3. Think about and emphasise sections which the
participants might find difficult and common
questions they may ask.
4. Ask series of questions to find out if participants
did understood the lecture
5. Divide the class into four groups for group
discussions / Quiz
6. Try to simulate situations at the participants’ place
of work during discussions and while answering
questions
Table 5.
Summary of session on the treatment of malaria.
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Oral Quinine is used or the combination of AL or AA is used [8].
Note THAT for pregnant women with co-morbidities of HIV and sickle cell
anaemia, the above treatment shall be used.
4.1.3 Home management of uncomplicated malaria
AL is the combination drug of choice for treatment of uncomplicated malaria for
children below five (5) years of age. Essential skills in behaviour change communi-
cation are thus necessary for community based agents such as the PMVs to effec-
tively home manage uncomplicated malaria.
4.1.4 Treatment failure in uncomplicated malaria
Quinine shall remain the drug of choice for the management of malaria in the
event of treatment failure.
When treatment fails in pregnancy, though ACTs are not recommended in the
first trimester of pregnancy, their use shall however not be stopped in cases where
they are considered to be life-saving and other antimalarials are not suitable.
For second and third trimesters in pregnancy, Quinine or AL or AA combina-
tion therapies shall be used depending on which drug was first given. Usually, a
treatment option other than what was first given to the patient will be used where
treatment failure is established.
4.1.5 Treatment of severe malaria
Management of severe/complicated malaria requires parenteral treatment to
provide adequate blood-serum concentrations as quickly as possible initially; sub-
sequently it is reverted to oral treatment as soon as the patient’s condition permits.
IM/IV Quinine or I.M. Artemether shall be the drugs of choice for treating
complicated malaria. The necessary support therapy shall be provided as and when
appropriate.
The treatment of pregnant women with severe malaria shall be with Parenteral
Quinine (I.V. or I.M. in all trimesters) until the patient can take oral preparations.
I. M Artemether can be used for the second and third trimesters. Pregnant women
with co-morbidities of HIV and sickle cell anaemia shall be treated as above.
Note that:
□ Severe malaria is a Medical Emergency. So it should always be referred to
secondary Healthcare facilities immediately!
□ Severe malaria needs special attention because:
• It is associated with dangerous complications (See Section 2.1)
• It is a common cause of avoidable deaths from malaria
□ The correct use of ACTs is essential for the success of treatment.
4.2 Why government changed 1st line malaria treatment from CQ to ACTs?
CQ and SP are no longer effective in treating malaria in Nigeria due to high
treatment failures resulting from widespread resistance. Efficacy studies that test
the ability of antimalarial medicines to kill and clear malaria parasites have shown
that ACTs are better than chloroquine. Table 6 below describes the two older drugs
that are no longer indicated for malaria treatment.
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Artemisinin derivatives are the most effective drugs against malaria in the world
at the moment and yet if misused the parasites can potentially develop resistance to
them. Already there are some signs from Far East Asia that improper use and use of
poor quality ACTs is making the malaria parasites have some ability to withstand
treatment with ACTs causing cure to take longer to achieve.
A technique to prevent resistance developing to Artemisinin derivatives is to
combine them with other antimalarials so that as a combination there is less possi-
bility of the parasites developing mechanisms to avoid both medicines.
Note that: The objective of prompt and effective malaria treatment is to:
• Cure the disease and eliminate the parasites from the body
• Prevent progression to severe disease or death
• Prevent transmission to others
• Prevent the parasites developing resistance to the malaria treatment
• Minimise adverse drug reactions
4.3 The first line treatment of malaria
Below are details of the treatments for malaria as recommended by the Govern-
ment of Nigeria:
4.3.1 Artemether/Lumefantrine (AL)
This is a fixed dose combination of Artemether 20 mg and Lumefantrine 120 mg.
It exists as several brands which have been registered by NAFDAC for use in the
country. The combination is abbreviated sometimes as AM/LM. Table 7 below
describes the dosing for AL with respect to age and body weights.
NOTE: The tablets of Artemether/Lumefantrine can be in the form of plain
tablets or dispersible tablets. The only difference is that the dispersible tablets
dissolve when immersed in a liquid whereas the plain tablets have to be crushed to
make a mixture for children that cannot swallow tablets. Only ACT 1 and 2 have
dispersible tablets.
4.3.2 Artesunate + Amodiaquine (AA)
Artesunate + Amodiaquine is sometimes abbreviated as ASAQ. A fixed dose
combination pre-pack and a co-packaged pre-pack exist as is seen in Tables 8 and 9
below. There are three presentations of this combination, namely Infant, Child and
Adult. These age and weight specific blister packs are colour coded.
S / No Drug Comments
1. Sulphadoxine-
Pyrimethamine (SP)
Not recommended for treatment of malaria.
Reserved for intermittent preventive treatment (IPT) in
pregnancy
2. Chloroquine (CQ) Inadequate efficacy and therefore no longer recommended for
treatment of malaria in Nigeria
Table 6.
Older drugs for treatment of uncomplicated malaria.
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When using the co-packaged tablets of AS+AQ, the client should be instructed
that the.
Artesunate and Amodiaquine tablets must be taken together, at the same time.
ASAQ fixed dose combination (FDC) should be used whenever possible.
Side effects of ACT:
□ Artemisinins are generally well tolerated at the doses used to treat malaria.
□ The side effects from the Artemisinin class of medicines are similar to the
symptoms of malaria: nausea, vomiting, anorexia, and dizziness.
4.4 Second line treatment
The second line treatment for malaria in Nigeria is Quinine in tablet formula-
tion. The indication for using Quinine is where a patient has confirmed malaria and
Number of tablets and dosing times
Day 1 Day 2 Day 3
Weight / Age ACT pack 0 h0urs 8 hrs 24 hrs 36 hrs 48 hrs 60 hrs
5 to <15 kg / 6mths – 3 yrs ACT1 1 1 1 1 1 1
15 to <25 kg /4 – 8 yrs ACT2 2 2 2 2 2 2
25 to <35 kg /9 – 14 yrs ACT3 3 3 3 3 3 3
≥ 35 kg /> 14 yrs ACT4 4 4 4 4 4 `4
Table 7.
Dosage schedule for AL (AM 20 mg/LM 120 mg) showing the four weight and age categories.
Weight (kg) Age AS tablets (50 mg) AQ tablets (153 mg)
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
6.5 to <10 4 to 11 months ½ ½ ½ ½ ½ ½
10 to <22 1 year to <7 years 1 1 1 1 1 1
22 to <36 7 years to <14 years 2 2 2 2 2 2
36 and above 14 years and above 4 4 4 4 4 4
Table 8.
Dosage schedule for co-packaged pre-pack tables AS+AQ (AS 50 mg + AQ 153 mg) showing the four weight
and age categories.
Weight/Age Tablet strength Dosage regimen
4.5 kg to <9 kg
2 months - 11 months
25 mg/67.5 mg 1 tablet once daily for three days
9 kg to <18 kg
1 year to 5 years
50 mg/135 mg 1 tablet once daily for three days (or 2 tabs of 25/67.5 mg)
18 kg to <36 kg
6 years to 13 years
100 mg/270 mg 1 tablet once daily for three days (or 2 tabs of 50/135 mg)
36 kg and above
14 years and above
100 mg/270 mg 2 tablets once daily for three days
Table 9.
Dosage schedule for tables AS/AQ fixed dose combination pre-pack (AS 50 mg + AQ 135 mg) showing the four
weight and age categories.
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has already taken a full course of the first line antimalarial treatment, i.e. AM / LM
or AS+AQ, and has not recovered. Parasitological confirmation of the diagnosis
should be done with microscopy before prescribing oral Quinine.
Dosage: Quinine tablets (300 mg salt) are given as a dose of 10 mg/kg body
weight up to a maximum dose of 60 kg body weight, e.g., 600 mg every 8 hours for
7 days.
4.5 Good prescribing practices
NOTE THAT:
□ Malaria can be 100% cured by ACTs, but ONLY when used appropriately
□ The only ACTs recommended in the National Protocol are AM/LM and AS
+AM.
□ It is not advisable to use other non-recommended ACTs.
□ Artemisinin monotherapies are not recommended as treatment for uncom-
plicated malaria.
□ Use of antimalarials by patients that do not have malaria means patients are
taking medicines that they do not need, which could be dangerous.
□ Overuse of antimalarials also has economic consequences to patient & the
nation
It is good practice to strongly encourage the client to take a full course of
treatment and complete the dose, otherwise the patient will not get well. This
means that you, as the health provider, need to counsel the client by providing
health information and advice.
Clients need to know about:
□ the type of treatment they are receiving
□ how to take/give the medicine
□ the dosage required
□ importance of completing treatment
□ details of how to watch out for adverse drug reactions
Dosing advice to healthcare providers regarding treatment of their clients:
□ Always dispense the full 3-day course of medicines
□ Show the client how to split the tablet (if necessary) to get the correct dose.
This can be done by pressing a knife along the seam on the top of the tablet
□ If possible, have client take the first dose in front of you, so you can supervise
as needed
□ Refer the client to health facility if they have any indications for referral.
Dosing advice to healthcare providers regarding treatment of their clients:
□ They should always take the medicine with or right after meals with a full
glass of water
□ When using a co-packaged (two different drugs together) product, both
medicines must be taken together in correct doses.
□ To completely cure the illness, the full course of treatment (the correct
number of tablets taken at the correct number of times each day for the correct
number of days) must be taken.
□ Symptoms may not disappear immediately after taking the first dose.
Improvement may take up to two days.
□ If the client vomits within half an hour, then the dose should be repeated.
□ The client should take plenty of fluids to avoid dehydration and food to
maintain strength. Fluids that contain sugar or glucose are an advantage.
□ For small children, it helps to crush the tablets and mix it with fruit juices, or
sugar and clean water to make a solution that is easier to swallow.
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4.6 Demonstration exercise
Observe the commonly available ACTs and discuss dosage presentations, so also
how to crush and split tablets for children (where necessary).
4.7 Group quiz
The facilitator will divide the class into four groups and each group will present
their answers to the quiz question below:
1.What is the drug of choice used in the treatment of uncomplicated malaria in
Nigeria excluding pregnant women?
Answer:
The anti-malarial drug of choice is: Artemeter - Lumefantrine (AL).
Alternatively: Artesunate + Amodiaquine (AA).
2.What drugs are used for severe malaria treatment?
Answer:
□ Parenteral drugs (IM or IV route) are required
□ IM or IV Quinine is the drug of choice.
□ Injectable Artemether is an alternative choice
□ Dosages are given in the treatment guidelines.
3.Which drug is used for treatment failure?
Answer:
□ Oral Quinine (after laboratory confirmation and ruling out other causes of
fever)
□ In pregnancy depending on the alternatives available and the trimester of
pregnancy (refer to Guidelines).
4.What drugs are used for treating uncomplicated malaria in pregnancy &What
is the dose?
Answer: Artesunate-Amodiaquine or Artemether-Lumefantrine in the 2nd and
3rd trimesters; Quinine tablets or Quinine-Clindamycin in the first trimester of
pregnancy. Refer to guidelines for dosage.
5.What drug is used for Intermittent Preventive treatment (IPT) of malaria in
pregnancy?
Answer: Sulphadoxine - Pyrimethamine (SP) (Discuss why … ..Refer to treat-
ment guidelines).
4.8 Role play
A volunteer from the class will be the health provider in a premises. Another
volunteer pretended to be a client presenting with malaria symptoms. On provision
of a complete ACT regimen, the client decides to take and pay for an incomplete
treatment.
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What will be your response in the situation and how will you convince the
client?
4.9 Reflection on module
Think about the topics you have just been discussing. How will you use the new
knowledge you have gained when you go back to your premises? Use the questions
below to help you reflect on this. Record your thoughts on paper for discussions.
1.Outline the treatment of both uncomplicated and severe malaria?
2.What other treatments have you learnt today?
3.How will this new information be useful when you go back to work?
4.What other questions do you now need to ask the trainer and get answers for?
5. Indications for referral
Table 10 below describes the training module on referrals of malaria patients.
This module comprises the session objectives, learning objectives, time duration for
the module, training materials needed, methods used and other relevant instruc-
tions that will assist facilitators to adequately explain referrals and its approaches.
Emphasise that certain conditions require a patient to be referred from a pri-
mary health center to a higher level facility for treatment. These conditions are
referred to in this module as indications for referral.
5.1 Conditions requiring referral
The indications for referral from a primary to a secondary or tertiary health
facility are when:
□ One or more danger signs are present
□ The patient has features of severe malaria
□ The patient is on recommended malaria treatment, but there is no improve-
ment after 48 hours
□ The client is not complying with treatment, because of vomiting or are
otherwise unable to take drugs by mouth
□ The client has adverse drug reactions to the ACT medicine that prevents him /
her from taking / completing treatment
□ You are unsure of the client’s illness or condition
□ The patient is having fever every day for seven or more days
Those patients who are not severely ill but have one or more indications for
referral should be referred with a referral form / letter. Patients who are severely ill
as shown by the presence of danger signs or features of severe malaria should be
given pre-referral treatment.
5.2 Treatment failure
The recurrence of P. falciparum malaria usually results due to either a re-
infection or recrudescence / failure. Failure in treatment is defined as the failure to
effectively clear malaria parasites from the blood or can also be described as the
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inability to resolve clinical symptoms despite administration of antimalarials.
Treatment failure can result from so many causes.
• Vomiting or poor absorption of drug – the patient or the caregiver usually gets
confused on what to do should the drug get vomited.
Session Objectives To identify cases requiring referral from the
signs and symptoms presented
To identify cases of treatment failure
To understand the causes of treatment
failure
To understand and identify danger signs
Duration 40 minutes
Learning objectives
At the end of the session, participants should be able to:
Know the conditions requiring referral
Applying the knowledge of conditions
requiring referral to practice
Appreciate and identify when a treatment
has failed
Be able to refer patients to the appropriate
health facility
Be able to identify danger signs
Training Materials Participant’s manual Pens & Notebook
Slides Laptop computer





Instructions for the facilitator 1. Begin the session by explaining the
learning objective of the session
2. Emphasise that reduction of death and
disability from severe malaria is a public
health priority for Nigeria. This can be
achieved by prompt referrals of severe cases.
3. Give the lecture on Indications for referral,
Treatment failure, Danger signs & Pre-
referral treatment.
4. Think about sections which the
participants might find difficult and
common questions they may ask.
5. Ask a series of questions to find out if the
participants did understood the lecture
6. Split the class into four groups to discuss
and answer the case studies
7. Try to simulate situations at the
participants’ place of work during
discussions and while answering questions
Table 10.
Summary of session on indications for referral.
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• Poor practices in prescribing – prescribing of incomplete course of treatment
increases the risk of treatment failure in malaria. This is a common practice
with PMVs. So always insist patients take home full / complete treatment
regimen, with proper advice on need to complete dose.
• Poor adherence: which may be due to several factors, including:
• ◦ information on correct regimen could be unclear to the patient or caregiver
ab-initio;
• ◦ some patients choose to stop taking treatment once the pressing symptoms
have resolved (a common problem with drugs having a very rapid
symptoms clearance), and some patients share the remaining treatment
with their family / friends;
• ◦ in cost-recovery systems, some patients cannot even afford a complete
course of their treatment, this presents a big challenge;
• ◦ Except for co-formulated products, patients may discard one of the
components of the combination that is associated with side effects or taste
hence its ineffectiveness.
• Drug quality – the use of substandard antimalarials with inadequate
recommended amount of active ingredient is a particular risk for drug. So ACT
quality must always be ensured by:
• ◦ sourcing from reputable pharmaceutical outlets or their representatives;
• ◦ proper storage all through the distribution system to avoid exposure to high
temperatures; and
• ◦ Avoiding administering expired drugs.
• Drug resistance in this case is the ability of a given parasite to survive or
multiply despite drug administration and absorption in doses equal to or higher
than the usually recommended, but within the tolerance of the subject.
Though treatment failure within 14 days of treatment with an ACT is very
unusual, a good history and proper examination is necessary to confirm any non-
malaria related causes of symptoms (refer to module 2). For instance, was a com-
plete course of ACT really taken, accompanied by food or not where appropriate,
and without vomiting in the first hour following any dose? So also, all treatment
failures must be confirmed parasitologically, and preferably by taking blood slides
for examination.
Note THAT, it is very important to keep good records of all confirmed treat-
ment failures and this information forwarded to appropriate health authorities, as
these failures need to be imputed into drug efficacy studies and these studies usually
lead to the observed changes in first-line antimalarial treatment.
• Whenever the treatment failure is after 14 days of initial treatment, it should
be considered to be a re-infections and another dose of ACT can be given.
• Treatment failures within 14 days of initial treatment should be treated with a
second-line antimalarial such as Quinine (for a total of 7 days).
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5.3 Danger signs
Generally, all danger signs are dangerous as the name indicates and emphasis
is on the need for an immediate referral. The most common danger signs
include:
• Convulsions or fits within the last two days or at present
• Not able to eat / drink or breastfeed (in children)
• Vomiting everything taken (severe vomiting) or severe diarrhoea
• Prostration indicated by extreme weakness, unable to sit or stand
• Altered mental state such as lethargy, drowsiness, confusion or
unconsciousness
• Breathing difficulties
• Severe dehydration shown by sunken eyes or if skin is pinched
• Severe anaemia or lack of blood shown by pale lips or palms
Note that:
All patients who have danger signs need urgent treatment at a secondary or
tertiary healthcare facility that has the equipment and expertise to handle emer-
gency conditions. To save this patient, you need to refer immediately.
5.4 Pre-referral treatment
All patients especially children who do not respond to treatment (with AL
within 24 hours) and the very ill (i.e., having any danger signs or features of severe
malaria) shall be referred immediately to the nearest hospital. Time is important at
this point and every hour of delay reduces the patient’s chance of survival. Pre-
referral treatment is used to increase the chance of the patient surviving long
enough to get to the health facility for further treatment.
5.4.1 Rectal Artesunate (or Artemether)
10 mg/kg body weight rectal artesunate is the recommended minimum dose.
Give a single dose as pre-referral treatment. The choices you have are artesunate or
artemether suppositories. This is repeated after 8 hours if transfer is delayed.
5.4.2 IM quinine
IM quinine 10 mg/kg. This is an alternative to Rectal artesunate. OR.
5.4.3 IM Artesunate or Artemether
IM artesunate 2.4 mg/kg single dose, OR IM artemether 3.2 mg/kg single
dose.
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5.5 Demonstration exercises
• A sample of Artesunate Suppository is torn to show participants its
presentation and the insertion process is described.
• Filling of Referral forms; done as a group work
Note that: Pre-referral treatment is not a replacement treatment for severe
malaria.
6. Malaria prevention
Table 11 below describes the training module on malaria prevention. This mod-
ule comprises the session objectives, learning objectives, time duration, training
materials needed, methods used and other relevant instructions that will assist
facilitators to adequately describe malaria prevention approaches.
6.1 Reasons for prevention
• Malaria can kill if it infects an individual, so we try to prevent it.
• Malaria will make you sick, and therefore make you unable to work, so people
may lose jobs /miss school etc.
• Malaria leads to poverty because Malaria and poverty are connected, you
cannot work and earn money or go to school for your future if you are ill with
Malaria, and you will need to spend a lot of money for treatment.
Note that:
• The first step towards malaria control is prevention.
• It costs far less to prevent malaria than it costs to treat it.
What must you do as a healthcare provider to help your clients prevent malaria?
• Provide health education to your community. As a health care worker you can
provide community members with information on prevention methods that
are available so that they can take steps to prevent malaria.
• Be a good example to the community by using the preventive methods you are
advocating, especially the ITNs.
What about the long awaited Vaccine for malaria?
An effective vaccine is not yet available for malaria, this is because of the
different phases which the parasite does exist within the human body giving it
different / contrasting properties. Although several vaccines are under develop-
ment. So far, a prospective vaccine candidate known as RTS-S/AS01 has shown
potentially promising results in clinical trials in Africa. Evidence-based policy rec-
ommendations on the issue are expected to be made this year (2015) depending on
data that will become available. While this wait goes on, prevention will then
depend on how to avoid parasites getting into the body.
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How do we stop parasites getting into our body?
The mosquitoes that spread malaria tend to bite at night between the hours of
10 p.m. and 4 a.m. They prefer to feed on human blood. After feeding, the
Session Objectives To understand reasons for emphasis on
prevention
To understand the various prevention
strategies
To identify reasons why many communities
do not embrace malaria prevention and how
best to encourage them
Duration 60 minutes
Learning objectives
At the end of the session, participants should be able to:
Know the various prevention methods
Be able to appropriately treat and hang an ITN
Be able to appropriately advice clients on
malaria prevention measures
Know the various locally circulated myths
about malaria and how to address them
Understand the various excuses given by
clients for not taking prevention and how to
persuade them against such negative acts
Training Materials Participant’s manual Pens & Notebook
Slides Laptop computer






Notes to facilitators 1. Begin the session by explaining the
objective of the session
2. Emphasise that reduction in death /
disability from malaria and reduction in
cost / stress of disease its treatment could be
achieved by effective prevention strategies.
3. Think about sections which the
participants might find difficult and
common questions they may ask.
4. Give participants opportunities to air their
various contributions / experiences and
myths.
5. Ask a series of questions to find out if the
participants are following.
6. Try to simulate situations at the
participants’ place of work during
discussions and while answering
questions.
Table 11.
Summary of session on malaria prevention.
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mosquitoes rest inside the house, usually on the walls. Common ways of preventing
malaria take advantage of these characteristics of the mosquito vector.
Key elements for transmission of malaria (as discussed in module 1.3) are:
• The malaria parasite itself,
• The transmitting agent (i.e. the vector mosquito), and
• The reservoir of the disease (i.e. people carrying the parasites in their blood).
The general objective of preventive efforts are:
1.Reducing vector-host contact: Since the mosquito must feed once on an
infected host to acquire the malaria parasite and once on an uninfected person
to transmit it, reducing host-vector-host contact is an effective way of
reducing transmission.
2.Reducing the longevity and abundance of adult mosquito population: The
more the mosquito population in an area the greater is the probability of
transmission. So, reducing the longevity and abundance of adult mosquito
population in an area reduces probability of transmission.
3.Reducing suitable breeding sites (source reduction) wherever this is feasible
and sustainable.
How effective these strategies are will greatly depend upon how assiduously
they are applied. The Federal Ministry of Health in Nigeria has adopted and
prioritised these prevention strategies: Insecticide Treated Nets (ITNs), the Inter-
mittent Preventive Treatment (IPT) for pregnant women, Complementary and
increasing Indoor Residual Spraying (IRS), Environmental Management and larval
Source Management (to reduce breeding where significant proportions of breeding
sites can be identified and targeted). They are the key prevention strategies to be
discussed.
Finally, there are on-going research initiatives looking to find new ways to tackle
malaria. For example, many scientists are involved in the search for new drugs and
vaccines (as stated earlier), which will be safe, effective, and with affordable price
tags, that could change our thinking on conquering malaria. Similarly, due to drug-
resistance, particularly with Plasmodium falciparum, new medications are con-
stantly being tested. A combination of all efforts towards fighting malaria put
together had reduced the mortality of malaria greatly over the years; the major aim
now for governments and all other partner organisations such as the WHO, Roll
Back Malaria (RBM), Society for Family Health (SFH), Malaria No More (MNM),
etc. is to get to a point where deaths from malaria are eliminated through effective
treatment and prevention strategies.
6.2 Insecticide treated nets (ITNs)
An ITN provides effective barrier between the person who is sleeping under it
and the mosquito vector. It reduces the opportunity for mosquito to bite and infect.
The impregnated insecticide also acts to kill and repel any susceptible vector that
rests on the net. An Integrated Vector Management System (IVMS) for malaria
prevention is also in place in the country and is a combined approach involving the
distribution of Insecticide Treated Nets (ITNs) as the major approach this involves
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all form of deliveries such as free public sector donation campaigns either jointly
integrated with other health activities (such as vaccination campaigns, National
immunizations) or as stand-alone campaigns, to the free public sector routine
distributions such as ANC and EPI services, and the subsidised and at cost sales
through hospitals, clinics and at PMV outlets.
Insecticide treated bed nets can be either conventional ITNs or Long Lasting
Impregnated Nets (LLINs). Conventional ITNs, as the name implies must be
treated once or twice a year (usually dependent on the duration of the transmis-
sion). LLINs are nets, whose fabrics have been impregnated with insecticides by a
special technique from the source, so that the insecticidal effect is maintained for as
long as the net can withstand daily usage, i.e. usually 3–5 years or about 20 washes.
Figure 4 below shows an example of an impregnated bed net hung outside to
protect people from vector transmission within a garden. Total access to LLIN is the
ultimate aim in public health and public sector distributions focuses on children
under 5 years of age and pregnant women.
6.3 Intermittent preventive treatment (IPT) during pregnancy / special care
patients
Currently, the most preferred intervention to prevent malaria in pregnancy is
the use Intermittent Preventive Treatment (IPT) apart from ITNs. And this is based
on the use of anti-malaria drugs that are usually given in treatment doses at some
defined intervals after quickening (16 gestational weeks). This serves to reduce
malaria parasitaemia which usually leads to poor pregnancy outcomes. IPT with
other products like haematinics and anthelmintics are preferably provided as part of
a comprehensive antenatal package. Every pregnant woman should also have access
to insecticide treated nets (ITNs) in addition to the IPT, which should be used
throughout the pregnancy as an additional method of malaria prevention.
Drug of Choice for Intermittent Preventive Treatment (IPT) Sulphadoxine -
Pyrimethamine (SP) is a combination drug (Sulphadoxine 500 mg + Pyrimethamine
25 mg) and shall be reserved only for Intermittent Preventive Treatment (IPT).
6.4 Indoor residual spraying (IRS)
Indoor residual spraying with an insecticide is sprayed on the wall every four or
six months to kill mosquitoes that rest on the wall to digest its blood meal. Before
and after feeding on a person, the mosquito rests on the wall where it picks up some
of the insecticide which eventually kills it. IRS is a very effective way of preventing
malaria.
Figure 4.
An impregnated bed net (LLIN) being hanged in a garden.
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Although this method is complementary to ITN distributions, it will form an
important and increasing part of the preventive strategy. Scenarios that are poten-
tial focus for IRS include:
• Areas where IRS has advantages to ITNs or has a synergistic effect (e.g. in and
around densely populated cities).
• Areas having a short and usually a malaria transmission season which is limited
and where the addition of the sprays can make local elimination possible (e.g.
the Sahel savannah in the North-East of this country).
• Areas where using treated nets shows to be difficult to implement (e.g.
consistent low use rates found with some communities).
• Institutions with marked populations such as boarding schools, army and
police barracks etc. the use of ITN seems more challenging in such places.
6.5 Other vector control interventions (environmental & Larval source
management)
These include Environmental Management (EM) and Larval control strategies
by using larvicides, predators or growth inhibitors.
6.5.1 Environmental management
Management of the environment to reduce breeding sites of the Anopheles
vector usually revolves round source reduction, and this is by targeting mosquito
breeding sites with the objective of reducing the availability of suitable breeding
sites. This will focus on man-made breeding sites in urban and peri-urban settings,
construction sites, agriculture projects etc. It should be note THAT Anopheles does
not breed in garbage or polluted gutters. So removal of garbage / filth is good for
public health in general, and reduces the number of nuisance mosquitoes. But
however, it has little impact on malaria control directly. The life span of an Anoph-
eles mosquito is between 2 and 3 weeks, if breeding is curtailed, the population of
mosquitoes will drastically drop due to this short life span.
To prevent breeding of mosquitoes, every householder must ensure that there is
no water collection around their houses.
6.5.2 Larvivorous fish (biological control)
Different predator fish species have been widely used to protect public health,
since early 1903. One of the most widely used and successful control agent against
mosquito larvae is the mosquito fish Gambusia affinis also called top water minnow.
Another fish which has received the most attention as a mosquito control agent is
Poecilia reticulata, the common guppy [7].
6.5.3 Chemical larviciding
Chemicals are used in breeding sites that cannot be drained, filled or where other
larval control methods are impossible to implement or too expensive. This method
is good only for vectors which tend to breed in semi-permanent or permanent water
bodies that can be identified, and where the population of the human to be
protected is sufficiently high to justify such treatment. Thus, larvicides are
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restricted to urban areas, barracks, labour or refugee camps and development
project sites.
The residual effect of larviciding conducted varies considerably depending on
the type of the breeding places and quality of the water, but is relatively short for
most larvicides. Such larvicide treatment must be repeated at fairly short cycles
which may vary from two to ten weeks. Temephos and Fenthion are some of the
most commonly used larvicides [10].
6.5.4 Use of screens in homes
House protection with screening of windows, eaves and doors is an effective
method of reducing human-vector contact, if properly implemented and maintained.
Screens are popular, cheap and accessible to most members of the community.
6.5.5 Mosquito coils, repellents, protective clothing, and others
The use of protective cloths and repellents are indicated for people who are
mostly outdoors during peak vector biting periods. Repellents have a very short
duration of effect in most cases and are costly. Aerosols and mosquito coils are
mostly popular in urban areas. Protective cloths usually covers most of the body, i.e.
long sleeve shirts and jackets, protective stockings with covering trousers can pro-
vide a certain level of personal protection from mosquito.
6.6 Demonstration session
• Demonstration on the appropriate spread of the ITN to suite both indoor or
outdoor use
• Demonstration on the proper method of treatment of the ITN using Deltamethrin.
6.7 Brainstorming session
• What advice would you as a PMV give a patient about prevention of malaria?
Answer:
• Use of insecticide treated materials should be encouraged.
• Mosquito screening devices in house designs and protective dressing.
• Use of insecticides and mosquito repellents.
• Environmental management especially destroying mosquito breeding sites.
• Which role can you play in the prevention and management of malaria in the
community?
Answer:
Discussions should be along these lines:
• Case management aspect
• Vector control, Behaviour Change Communication
• Health education and Community participation
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7. Discussion
A systematic review was conducted in 2017 on the effectiveness of different
malaria intervention programmes among Patent Medicine Vendors (PMVs) by the
authors of this book chapter [11]. The researchers tried to identify and review the
different studies addressing poor KAP on all relevant topics that had characterised
services rendered by the PMVs. The review showed that all studies analysed were
effective in improving KAP despite adopting different intervention approaches for
their different interventions with relatively wide range of topics all relating to
malaria.
An intervention conducted in 2014 to strengthen PMV Associations for an
improved malaria management [12], was also conducted in Nigeria just like the
present study, but was specifically concerned with the use of RDTs for effective
confirmatory test before commencement of treatment, this intervention training
was embarked upon to check indiscriminate use of antimalarials without a confir-
matory test. The use of RDTs was however treated in Section 3 of this training in
addition to other aspects of malaria. Other studies conducted in Nigeria had a wide
range of intervention focus such as PMVs knowledge and perception regarding the
ACT treatment [13], improving knowledge on Pharmacovigilance [14], Influence
of training on community malaria treatment and practices [15], training of
rural PMVs towards improving childhood malaria treatment / referral practices
[16], and primary care training for medicine vendors in rural communities of
Nigeria [17].
Many other intervention trainings regarding malaria were conducted in several
different malaria prone countries such as Pakistan, Kenya and Tanzania [18–24],
and each had a focus on improving the services of medicine vendors, but they all
had different approaches, aspects of malaria being treated and modes of delivery of
intervention.
In the course of developing this training manual, inputs were considered from
many malaria intervention trainings and studies, almost all the studies considered
tried to improve on the knowledge and practice of respondent [13–25], while only
three studies improved and assessed attitudes of respondents [12, 15, 20]. This
training module however tried to improve on all aspects of knowledge, attitudes
and practices of the respondents using its problem-solving approach to facilitate
understanding and thereby motivating trainees by using a combination of the
techniques / strategies used by all these studies and hence consolidating on their
successes.
The gains of a combination of strategies cannot be overemphasised, and this had
led to great successes in the fight against malaria in many parts of the malaria
endemic world leading to a WHO report claiming 1.5 billion malaria cases and 7.6
million deaths have been averted since the year 2000 [26]. The African countries
which shouldered more than 90% of the overall disease burden in recent years had
reduced its malaria death toll by 44%, from an estimated 680,000 to 384,000
annually [26]. However, for progress to be sustained, efforts have to be intensified,
particularly in those countries with the highest burden of the disease despite the
environmental, economic, political and other challenges discussed.
8. Conclusion
This paper puts forward a concise training module for everyday handlers of
malaria cases in sub-Saharan Africa. The training module comprising the basics in
the management of malaria such as basic information, its signs, symptoms/
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diagnosis, its treatment, referral and prevention as was conceptually meant for the
training of Patent Medicine Vendors but its relevance extends to all other categories
of health providers tasked with managing malaria. The topics and contents treated
had been carefully put together to cover the relevant aspects necessary to impact a
required improvement in knowledge, attitudes and practices (KAP) of the trainees
and other practicing healthcare providers alike. The emphasis placed on medicine
vendors is rooted to the fact that they had long been identified as the most
patronised and most commonly available group of healthcare providers within the
sub-Saharan African region on malaria issues, hence any intervention on their KAP
will hugely influence malaria epidemiology within the sub-region.
The peculiar mode of delivery of training used across the sections of the training
module included presentation of lectures, demonstration exercises, differential
diagnosis to distinguish malaria from other diseases with similar presentations,
quizzes / brainstorming exercises such as question and answer sessions, empathy
exercises, group discussions, handling of case studies, participation in role plays,
and reflections on each module with the facilitators was conceptualised due to the
realisation that the medicine vendors are deficient in their knowledge, attitudes and
practices with respect to malaria handling, that the various methods employed have
been proved to be effective in various stand-alone trainings and that collectively
employing all the various methods used will strategically improve on the KAP
generally.
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